Onward Medical Valuation

Is 63E undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 63E when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 63E's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 63E's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 63E?

Key metric: As 63E is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for 63E. This is calculated by dividing 63E's market cap by their current book value.
What is 63E's PB Ratio?
PB Ratio11.9x
Book€18.35m
Market Cap€218.68m

Price to Book Ratio vs Peers

How does 63E's PB Ratio compare to its peers?

The above table shows the PB ratio for 63E vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average2.5x
PUS PULSION Medical Systems
6.5xn/a€133.6m
SBS Stratec
1.8x25.4%€407.8m
DRW3 Drägerwerk KGaA
0.6x2.0%€826.8m
GME Geratherm Medical
1x89.5%€20.7m
63E Onward Medical
11.9x-1.6%€218.7m

Price-To-Book vs Peers: 63E is expensive based on its Price-To-Book Ratio (11.9x) compared to the peer average (2.5x).


Price to Book Ratio vs Industry

How does 63E's PB Ratio compare vs other companies in the DE Medical Equipment Industry?

2 CompaniesPrice / BookEstimated GrowthMarket Cap
MF6 MagForce
0.1x149.0%US$3.59m
MF6 MagForce
0.01xn/aUS$404.27k
No more companies available in this PB range
63E 11.9xIndustry Avg. 2.2xNo. of Companies2PB012345+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: 63E is expensive based on its Price-To-Book Ratio (11.9x) compared to the European Medical Equipment industry average (2.2x).


Price to Book Ratio vs Fair Ratio

What is 63E's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

63E PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio11.9x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate 63E's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 63E forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€4.81
€14.18
+194.7%
29.9%€20.00€8.70n/a4
Dec ’25€4.93
€14.18
+187.5%
29.9%€20.00€8.70n/a4
Nov ’25€4.94
€13.80
+179.4%
29.0%€20.00€9.10n/a4
Oct ’25n/a
€13.85
0%
28.4%€20.00€9.30n/a4
Sep ’25n/a
€13.85
0%
28.4%€20.00€9.30n/a4
Aug ’25€5.16
€13.85
+168.4%
28.4%€20.00€9.30n/a4
Jul ’25€4.81
€13.85
+187.9%
28.4%€20.00€9.30n/a4
Jun ’25n/a
€13.85
0%
28.4%€20.00€9.30n/a4
May ’25n/a
€13.85
0%
28.4%€20.00€9.30n/a4
Apr ’25€4.62
€14.47
+213.1%
30.2%€20.00€9.30n/a3
Mar ’25n/a
€14.70
0%
27.9%€20.00€10.00n/a3
Feb ’25€2.27
€17.05
+651.1%
17.3%€20.00€14.10n/a2
Jan ’25€3.07
€17.05
+455.4%
17.3%€20.00€14.10n/a2
Dec ’24€3.56
€17.05
+378.9%
17.3%€20.00€14.10€4.932
Nov ’24n/a
€17.05
0%
17.3%€20.00€14.10€4.942
Oct ’24€4.02
€17.05
+324.1%
17.3%€20.00€14.10n/a2
Sep ’24n/a
€17.05
0%
17.3%€20.00€14.10n/a2
Aug ’24n/a
€17.05
0%
17.3%€20.00€14.10€5.162
Jul ’24€5.16
€17.05
+230.4%
17.3%€20.00€14.10€4.812
Jun ’24€6.00
€17.05
+184.2%
17.3%€20.00€14.10n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies